12
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Role of cardiac markers in evaluation of suspected myocardial infarction

Selecting the most clinically useful indicators

, PhD
Pages 113-122 | Published online: 30 Jun 2015

References

  • Mercer DW. A historical background in cardiac markers. Med Lab Observer 1996; 28(7):45–51
  • Vaidya HC, Maynard Y, Dietzler DN, et al. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin Chem 1986; 32(4):657–63
  • Kagen L, Scheidt S, Butt A. Serum myoglobin in myocardial infarction: the “staccato phenomenon.” Is acute myocardial infarction in man an intermittent event? Am J Med 1977; 62(l):86–92
  • Puleo PR, Meyer D, Wathen C, et al. Use of a rapid assay of sub- forms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331(9):561–6
  • Wu AH, Wang XM, Gornet TG, et al. Creatine kinase MB isoforms in patients with skeletal muscle injury: ramifications for early detection of acute myocardial infarction. Clin Chem 1992; 38(12): 2396–400
  • Katus HA, Scheffold T, Remppis A, et al. Proteins of the troponin complex. Lab Med 1992; 23(5):311–7
  • Ohman EM, Armstrong PW, Christenson RH, et al, for the GUSTO Ila Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335(18):1333–41
  • Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac- specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335(18): 1342–9
  • Wu AH, Valdes R Jr, Apple FS, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994; 40(6):900–7
  • Wu AH, Clive JM. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain. Clin Chem 1997; 43(2):326–32

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.